UCL scientists identify new immunotherapy to combat hepatitis B virus by rss feed | May 14, 2021 | News Feeds Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world. Read Original Copy